Results 161 to 170 of about 529,890 (286)
Traffic Sign Recognition Based on the YOLOv3 Algorithm. [PDF]
Gong C, Li A, Song Y, Xu N, He W.
europepmc +1 more source
This study delineates macrophage heterogeneity along the acute kidney injury to chronic kidney disease transition. Single‐cell RNA sequencing reveals a TRAP5+ scar‐associated macrophage subset driven by Spp1–Cd44 signaling and mitochondrial metabolic reprogramming.
Chenxi Wang +13 more
wiley +1 more source
An improved lightweight algorithm for traffic sign detection. [PDF]
Xu J, Du Y, Yi Y, Du H.
europepmc +1 more source
E-YOLOv4-tiny: a traffic sign detection algorithm for urban road scenarios. [PDF]
Xiao Y +5 more
europepmc +1 more source
We identified the endothelial RAP2A as a regulator of inflammatory endothelial activation in experimental lung fibrosis and suggest that targeting RAP2A‐mediated signaling may represent a potential strategy to modulate endothelial–immune crosstalk during fibrotic lung injury.
Xiaolan Zheng +13 more
wiley +1 more source
Improved road traffic sign recognition from feature reconstruction. [PDF]
Huang G, Cao H, Sun J, Chen Z, Zhou Z.
europepmc +1 more source
Research on a Traffic Sign Recognition Method under Small Sample Conditions. [PDF]
Zhang X, Zhang Z.
europepmc +1 more source
We developed a macrophage‐based therapeutic platform, termed trackable tolerogenic macrophages (TTM), for dual‐function immunomodulation and visualization in vivo. TTM cells were engineered to overexpress PD‐L1, incorporate bioorthogonal cell surface tags, and load rapamycin for sustained release.
Yihui Wang +14 more
wiley +1 more source
Autotrinet YOLO triple attention framework for robust traffic sign detection. [PDF]
Dong WY, Chen YX, Zou GY.
europepmc +1 more source

